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Three novel peptide inhibitors of the SK,,< channels were purdied to homogeneity from the venom of the scorpion Androctonus ntauretanicus 
muuretunzcus using one step of RP-HPLC and competrtton assays with [“SI]apamin to rat brain synaptosomes PO,, PO? and PO, have K,, of 
100, 100 and 0.02 nM, respectively, for the apamm binding site. The sequence of PO3 was established and compared to that of other scorpion toxins 
active on K’ channels: it contains 31 residues and has a free carboxyl end. It shares sequence srmilarny wnh apamin and leiurotoxm 1. 
Scorpion toxin. Structure; Potassium channel; Apamin 
1. INTRODUCTION 
Scorpion venoms are known to contain toxic pol- 
ypeptides that specifically alter the gating properties of 
the voltage-dependent Na’ channel [1,2]. Efforts to 
characterize minor venom components have recently 
led to the discovery of some toxins able to act on K’ 
channel structures [3,4]. The wide diversity of K’ chan- 
nels has been particularly studied during the past dec- 
ade and there has been much work on toxins affecting 
different types of K’ channels. Some scorpion toxins are 
useful probes for elucidating the mechanism of action 
and the pharmacology of the different channels. Six 
toxin polypeptides active on K’ channels have been 
isolated from the venom of the Moroccan scorpion An- 
droctonus mauretanicus mauretanicus: one toxin (KTX) 
is specific for the large conductance Cal+ activated K’ 
channels (BK,,) of invertebrate neurons and rabbit 
sympathetic neurons [5]. The five other peptides com- 
pete for binding to rat brain synaptosomes membranes 
with radioiodinated apamin ([“51]apamin), a derivative 
of a toxin from the honey bee venom Apis melfijka [6,7], 
indicating that these toxins interact specifically with the 
small conductance Ca’+-activated K’ channel (SK,,). 
We report the chemical and biological characterizations 
of one of these polypeptides. Its sequence contributes to 
the analysis of toxin structure-activity relationships and 
the understanding of its mode of action. 
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2. MATERIALS AND METHODS 
The venom of Androctonus rwuretumcus muurrtanicus was obtained 
by manually stimulating the animals (every 100 ~1 of venom yielded 
8 24 mg of lyophilised protein). UV grade acetomtrtle was from Fisons 
Sctenttfic (UK), trifluoroacetrc acid (TFA) was from Baker (UK) and 
all the other analytical reagents were from Merck (Germany) Bovine 
serum albumin (BSA) and apamin were from Sigma Carboxypepti- 
dase P (CPase P) was from Boehringer (Germany). The water used to 
prepare solvents and buffers was purified with the Mrlh/Ro/M~Ih Q 
system from Millipore. Reverse-phase HPLC wascarried out, at WC, 
on a Merck 4 x 250 mm analytical column prepacked wrth a hchro- 
sphere 5 pm 100 RP-18 as previously described [5]. Additional details 
concernmg all the chromatographtc steps are given m the text and 
figure legends. Samples for biologrcal assays were lyophiltzed m the 
presence of 0.1% BSA. hlectrophoresis was performed at pH 8.5 on 
homogeneous high density Phast-gel using a Phast-system (Pharma- 
cia, Sweden) with migratton towards the cathode. The peptides (200 
pg) were stained with silver using the Pharmacia development tech- 
nique File 211, The toxin was reduced with dithroerythrrtol and S- 
alkylated with rodoacetic acid as described previously [S]. The reduced 
carboxymethylated toxin (RCM-toxin) was desalted by chromatogra- 
phy on RP-18 HPLC columns. Electrospray mass spectrometry was 
performed by Neosystem Laboratoire (Strasbourg, France). Auto- 
mated Edman degradation was performed on a Beckman 890 MM 
sequencer and the characterrzatron of phenylthiohydantoin dertva- 
ttves was carrred out by C,,-HPLC as descrtbed [9]. One nmol of PO5 
was digested with CPase P (15% by weight) according to the manufac- 
turers‘ mstructions. Toxicity in vivo was tested on male C57B1/6 mice 
by mtracerebroventrtcular injections (I.c.v.) as described [7]. Mono 
“51-labelled apamin was obtamed and used in competitton assays with 
rat brain synaptosomal fraction (P,) as described [lo]. 
3. RESULTS AND DISCUSSION 
The venom was dialyzed against distilled water to 
eliminate salts and peptides with MW < 1,000. One sin- 
gle step of reverse-phase HPLC chromatography (Fig. 
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Ftg. 1. Purtfication of the toxms. Reverse-phase HPLC on Ltchrospher 100 RP-I 8 t5ym) of Androctonus mauretanicus mauretanicus dtalyzed venom 
(0.8 mg) Solvent A. 0.1% TFA: solvent B. acetomtrtie/O.l% TFA: linear pradtent from 5 to 35% B in 100 min: flow rate 1 m)/min: absorbance 
umt full scale at 21.5 nm = I. Arrows indtcate the fractions able to compete wtth (“‘I]apamm bound to tts receptor sate on rat bram synaptosomal 
membranes. Inset. Competitive mhibitton of [“‘I]apamin bindmg to rat bram synapttc membrane by PO,. fIO is the bmdmg of [“‘I]apamm (10 pM) 
in the absence of competttor and B IS the bmdmg in the presence of the mdicated concentrations of nattve PO5 (160 pg of PZ membranes m 500 
~1 of 20 mM Trts. 10 mhl KC1 medtum. pH 7 5) The bound radtoactivtty was determmed m the pellet after centrifugatton. Pomts are the mean 
of at least two experiments conatstmg of quadruplate assays 
1) led to five fractions inhibiting [“IJapamin binding to 
rat brain synaptosomes; retention times (RT) were 44.9 
min for PO,, 46.6 min for PO?, 49.5 min for PO,. 53.2 
min for PO, and 55.12 min for PO,. PO, is the previ- 
ously described KTX [5]. Fractions PO,, PO, and PO, 
were homogeneous as assessed by polyacrylamide gel 
electrophoresis and RP-HPLC chromatography on a 
C,, column using different elution conditions (not 
shown). PO, was the most toxic fraction to mouse, and 
the strongest competitor of apamine binding to its site, 
and was further studied. It amounted to 0.05% by 
weight of the venom. Its LD,,, by intracerebroventricu- 
Jar (i.c.v.) injection to the mouse. was 20 ng or 4.5 pmol 
for a 20 g animal (as compared to 4 pmol for apamin). 
The inhibition by PO, and also by PO, and PO, of the 
binding of the labelled [“‘I]apamin to its receptor site 
in rat brain synaptosomes, is shown in Fig. 1 (inset). 
The derived Kd. calculated from the experimental Ku5 
(20 PM), was 13 pM, very similar to that of apamin. 
The first 30 residues of RCM-PO, (0.5 nmol) were 
190 
identified by automated Edman degradation with an 
initial degradation yield of 37% and a repetitive yield of 
93%. The C-terminal residue was identified as His by 
CPase P digestion. The molecular mass of PO, calcu- 
lated from the sequence of 31 residues was in perfect 
accordance with that obtained by electrospray mass 
spectrometry: 3,415.4 t 0.6 Da. The level of similarity 
between PO, and leiurotoxin I (LTX I) [ 111, also known 
as scyllatoxin [12]. a toxin found in the venom of the 
scorpion Lriuvus yuinyuestriatus hrbturus, was very 
high: 87% sequence identity. LTX I has been found both 
with a free and with an amidated histidine residue in the 
C-terminal position, and the two peptides exhibit differ- 
ent chromatographic properties on HPLC [12]. An ana- 
log of PO, with an amidated C-terminal His was synthe- 
sized: sPO,-NH, [13]. The elution of a mixture of the 
natural and synthetic peptides on C,,-RP HPLC gave 
different retention times (RT of 51.33 min for sPO,-NH, 
and 53.2 for native PO,). Moreover, sPO,-NH2 was 
more basic than PO, in polyacrylamide gel electropho- 
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+- POS-NH2 lower affinity of LTX I for the apamin binding site (100 
+ PO5 pM for LTX I instead of 20 pM for PO,). 
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Fig. 2. Co-injection of PO, and sPO,-NH2 on C18-RP-HPLC (same 
conditions as above). Inset. Homogeneous gel electrophorests pH 
8.50; mtgration toward the cathode (up); lane I (200 pg): lane 2, 
mtxture of native PO5 (50 pg) and sPO,-NH, (200 pg) 
resis (Fig. 2). Finally, electrospray mass spectrometry 
(three different experiments) showed that the MW of 
the two peptides differed by only 1, proving that the 
C-terminal residue of PO, was free (3.414.6 & 0.7 for 
sPO,-NH, instead of 3.415.4 + 0.6 Da for PO,). None 
of the four other peptides of the venom able to compete 
with [‘2sI]apamin for its binding site exhibited the same 
RT as sPO,-NH,, indicating that only the PO, with a 
free C-terminal end was found in the natural secretion. 
The PO, amino acid sequence was compared with the 
sequences of apamin and LTX I, other peptide inhib- 
itors of the SKc, channel (Fig. 3) and other small scor- 
pion toxins active on K’ channels of different types (the 
A-type K’ channel, the delayed rectifier K’ channel or 
the BK,, channel), i.e. noxiustoxin (NTX), iberiotoxin 
(IbTX), kaliotoxin (KTX) and charybdotoxin (ChTX) 
[3-51. The sequence Arg-Arg-Cys-Gln of the N-terminal 
part of PO, was also found in the C-terminal a-helical 
part of apamin. The corresponding sequence in LTX I 
is Arg-Met-Cys-Gln. However, polyclonal antibodies 
raised against apamin [14] were not able to recognize 
PO, in liquid radioimmunoassay. The adjacent Arg res- 
idues were reported to be crucial for the pharmacologi- 
cal activity of apamin [6,7,15]. Furthermore, the bind- 
ing of the synthetic [“‘I]Tyr LTX I to its receptor was 
completely lost after modification of Arg-6 and Arg-13 
[16]. Arg-6 and Arg-7 of PO, might well be also located 
in a part of the molecule proposed to be an a-helix in 
LTX I (from Arg-6 to Gly-16) [17]. The substitution of 
the Arg-7 of PO, by Met in LTX I could explain the 
Highly conserved amino acid residues (Fig. 3, resi- 
dues in bold) are found in PO, and the other scorpion 
toxins active on K’ channels. The position of the three 
disulfide bridges of PO, has been defined [13]. This is 
in agreement, for PO, and LTX I, with a spatial ar- 
rangement of the a-helix and the P-sheet similar to those 
of ChTX and IbTX, although the /?-strand I is missing 
and the loops connecting the different part of the a-helix 
and the P-strand II vary in length between the toxins 
[l&20]. ChTX and IbTX are active on different types 
of K’ channels [3]: they have two charged surfaces ac- 
cording to refined models of solution conformations 
obtained by ‘H nuclear magnetic resonance: one is lo- 
cated in the helix and one in the C-terminal region. 
Among the positively charged amino acids of PO,. the 
Lys residues in position 20 and 25 are located in the 
strongly conserved region. From NMR data of LTX I, 
an antiparallel P-sheet could be located from Leu-18 
with a tight turn at Gly-233Asp-24 position. The se- 
quence Gly-Lys-Cys XXX Lys-Cys with Lys-Cys lo- 
cated in antiparallel P-sheet and XXX as tight turn, is 
also conserved in ChTX and IbTX (type 1 p-turn at 
residues Gly-30-Lys-3 1). This sequence could be impor- 
tant for the conformation of the toxins. The side chains 
of these two Lys appear on one of the solvent exposed 
faces of the P-sheet [l&20]. The interaction between 
ChTX and its receptor site involves local electric fields, 
made of both negative charges on the H5 region of the 
channels, as demonstrated by electrophysiological stud- 
ies after mutation of the K’ channel coded by the 
Slraker gene of Dvosophilu r~~eguloguster xpressed in 
Xenopus oocytes [21], and positive charges of the toxin. 
Studies with engineered ChTX suggest that the Lys-27 
plays a major role by fixing the toxin to the external 
Apamin CNCKAPETALCwQH* 
PO5 
LTX 
TVC-NL-LSCRSL-GLL-G-KCIGVKCECVKH 
AFC-NLRMCQLSCRSL-GLL-G-KCIGDKCECVKH* 
KTX GVEINVKCSGSPQCLKPCKDA-GMRFG-KCMNRXCHCTPK# 
NTX TI-INVKCTSPKQCSKPCKELYGSSAGAXCMNGKCKCYNN 
IbTX ZFT-DVDCSVSKECWSVCKDLFGVDRG-KCMGKKCRCYQ 
ChTXl ZFT-NVSCTTSKECWSVCQRLHNTSRG-KCMNKKCRCYS 
ChTX2 ZFT-QESCTASNQCWSICKRLHNTNRG-KCMNKKCRCYS 
Ftg. 3. Sequences stmilartties between POj and other toxins active on 
K’ channels. Apamm from bee venom iipls r~ll~eera; PO, (this work): 
LTX. leiurotoxm I (scyllatoxm) from Lerurus qurrzquestr~arus hebrueus, 
KTX. kahotoxin from Amiroctonus mauretum’cus mauretamcus, NTX. 
noxtustoxin from Cenrrzrrodes no.ww; IbTX, iberiotoxm from Butlrus 
tamulus; ChTX, and ChTX?. charybdotoxin 1 and 2 from Leurzts 
quinquestriatu hebrueus. *Amtdated C-terminal end: LTX can be 
found with a free or amtdated C-terminal. #Sequence of KTX cor- 
rected according to [23]. 
191 
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mouth of the K’ channel, the blockade being achieved 
by the plugging of the channel pore by the toxin [22]. 
It is tempting to propose, as already suggested [16], 
that the blockade of K’ channels by these toxins could 
be mainly due to the conserved sequence found in the 
C-terminal part and the antiparallelp-sheet and that the 
specificity for one or another type of K’ channel could 
be due to additional structural elements, some of them 
contained in the N-terminal cl-helicoidal part of the 
molecule, Future studies using different synthetic ana- 
logs of PO, and KTX will help to clarify these points 
and could contribute to the analysis of the wide diver- 
sity of K+ channels. 
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